AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
110 hedge funds and large institutions have $368M invested in AVEO Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% more funds holding
Funds holding: 77 → 110 (+33)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
110
Holding in Top 10
1
Calls
$6.02M
Puts
$194K
Top Buyers
| 1 | +$21.9M | |
| 2 | +$21.6M | |
| 3 | +$19.4M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$18.2M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$16.8M |
Top Sellers
| 1 | -$32.5M | |
| 2 | -$30.6M | |
| 3 | -$13.7M | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$7.69M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$5.4M |